Name
INOSINE PRANOBEX
Mode of Action
INOSINE PRANOBEX APPEARS TO OWE ITS ACTIVITY IN VIRAL INFECTIONS MORE TO ITS CAPACITY TO MODIFY OR STIMULATE CELL-MEDIATED IMMUNE PROCESSES THAN TO A DIRECT ACTION ON THE VIRUS.
Dosage
MUCOCUTANEOUS HERPES SIMPLEX, 1 G 4 TIMES DAILY FOR 7-14 DAYS ADJUNCTIVE TREATMENT OF GENITAL WARTS, 1 G 3 TIMES DAILY FOR 14-28 DAYS SUBACUTE SCLEROSING PANENCEPHALITIS, 50-100 MG/KG DAILY IN 6 DIVIDED DOSES
Drug Group
[ANTIVIRAL] , [IMMUNOMODULATOR]
Cross Reaction
NONE REPORTED
Drug Interaction
Drugs Side Effect
Drug Categories
Special Precaution
Drug Safety
Monograph